HIVEC+TUR (n = 128) | HIVEC (n = 37) | P | |
---|---|---|---|
Age (years) | 50.7 ± 1.9 (37–66) | 51.6 ± 2.3 (39–66) | 0.07 |
Sex, n (%) | |||
Male | 86 (67.2) | 22 (59.5) | 0.09 |
Female | 42 (32.8) | 15 (40.5) | 0.07 |
Disease course (days) | 11.4 ± 1.3 | 11.3 ± 1.6 | 0.07 |
Tumor location, n (%) | |||
Side wall | 35 (27.3) | 1 (2.7) | 0.06 |
Posterior wall | 27 (21.1) | 2 (5.4) | 0.08 |
Top area | 19 (14.8) | 1 (2.7) | 0.08 |
Triangle area | 10 (7.8) | 17 (45.9) | 0.06 |
≥ two tumors | 37 (28.9) | 16 (43.2) | 0.07 |
Tumor size, n (%) | |||
≥ 0.5 cm | 66 (51.6) | 28 (75.6) | 0.07 |
< 0.5 cm | 62 (48.4) | 9 (24.4) | 0.09 |
Tumor stage, n (%) | |||
Tis | 13 (10.2) | 0 | 0.06 |
T1 | 73 (57.0) | 9 (24.3) | 0.06 |
T2 | 42 (32.8) | 28 (75.7) | 0.08 |
Tumor differentiation, n (%) | |||
G1 | 41 (32.0) | 11 (29.7) | 0.08 |
G2 | 54 (42.2) | 14 (37.8) | 0.08 |
G3 | 33 (25.8) | 12 (32.4) | 0.75 |